Cargando…

Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy

BACKGROUND: Postictal psychosis (PIP), an episode of psychosis occurring after a cluster of seizures, is common and may be associated with profound morbidity, including chronic psychosis. Symptoms are often pleomorphic, involving a range of psychotic symptoms, including hallucinations and disorders...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, Eric M, Lafayette, Jennifer M, Bromfield, Edward B, Fricchione, Gregory
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555577/
https://www.ncbi.nlm.nih.gov/pubmed/16859554
http://dx.doi.org/10.1186/1744-859X-5-9
_version_ 1782129357468205056
author Morrow, Eric M
Lafayette, Jennifer M
Bromfield, Edward B
Fricchione, Gregory
author_facet Morrow, Eric M
Lafayette, Jennifer M
Bromfield, Edward B
Fricchione, Gregory
author_sort Morrow, Eric M
collection PubMed
description BACKGROUND: Postictal psychosis (PIP), an episode of psychosis occurring after a cluster of seizures, is common and may be associated with profound morbidity, including chronic psychosis. Symptoms are often pleomorphic, involving a range of psychotic symptoms, including hallucinations and disorders of thought. PIP is treatable and may be averted if presymptomatic risk factors are considered in susceptible patients and treatment is initiated. CASE PRESENTATION: In this report, we present an illustrative case of PIP. The patient, Mr. R, presented to our emergency room with delusions and disordered thought process following a cluster of seizures. He recovered after admission, sedation and treatment with antipsychotic medication. DISCUSSION: A list of presymptomatic risk factors is established based on review of current literature. Identification of such risk factors may potentially help with prophylactic treatment; however, little empirical research exists in this area and treatment guidelines are thus far largely based on expert opinion. Further, while the neurobiology of schizophrenia is advancing at a rapid pace, largely due to advances in genetics, the pathophysiology of PIP remains largely unknown. Considering the progress in schizophrenia research in the context of the clinical features of PIP and existing studies, potential neurobiological mechanisms for PIP are herein proposed, and further genetic analyses, which may help identify those susceptible, are warranted. CONCLUSION: While PIP is an important problem that may present first to general hospital psychiatrists, as in the case presented, this topic is under-represented in the medical psychiatry literature. As discussed in this article, further research is needed to develop presymptomatic screens and treatment pathways to help prevent morbidity.
format Text
id pubmed-1555577
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15555772006-08-26 Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy Morrow, Eric M Lafayette, Jennifer M Bromfield, Edward B Fricchione, Gregory Ann Gen Psychiatry Case Report BACKGROUND: Postictal psychosis (PIP), an episode of psychosis occurring after a cluster of seizures, is common and may be associated with profound morbidity, including chronic psychosis. Symptoms are often pleomorphic, involving a range of psychotic symptoms, including hallucinations and disorders of thought. PIP is treatable and may be averted if presymptomatic risk factors are considered in susceptible patients and treatment is initiated. CASE PRESENTATION: In this report, we present an illustrative case of PIP. The patient, Mr. R, presented to our emergency room with delusions and disordered thought process following a cluster of seizures. He recovered after admission, sedation and treatment with antipsychotic medication. DISCUSSION: A list of presymptomatic risk factors is established based on review of current literature. Identification of such risk factors may potentially help with prophylactic treatment; however, little empirical research exists in this area and treatment guidelines are thus far largely based on expert opinion. Further, while the neurobiology of schizophrenia is advancing at a rapid pace, largely due to advances in genetics, the pathophysiology of PIP remains largely unknown. Considering the progress in schizophrenia research in the context of the clinical features of PIP and existing studies, potential neurobiological mechanisms for PIP are herein proposed, and further genetic analyses, which may help identify those susceptible, are warranted. CONCLUSION: While PIP is an important problem that may present first to general hospital psychiatrists, as in the case presented, this topic is under-represented in the medical psychiatry literature. As discussed in this article, further research is needed to develop presymptomatic screens and treatment pathways to help prevent morbidity. BioMed Central 2006-07-21 /pmc/articles/PMC1555577/ /pubmed/16859554 http://dx.doi.org/10.1186/1744-859X-5-9 Text en Copyright © 2006 Morrow et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Morrow, Eric M
Lafayette, Jennifer M
Bromfield, Edward B
Fricchione, Gregory
Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
title Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
title_full Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
title_fullStr Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
title_full_unstemmed Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
title_short Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
title_sort postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555577/
https://www.ncbi.nlm.nih.gov/pubmed/16859554
http://dx.doi.org/10.1186/1744-859X-5-9
work_keys_str_mv AT morrowericm postictalpsychosispresymptomaticriskfactorsandtheneedforfurtherinvestigationofgeneticsandpharmacotherapy
AT lafayettejenniferm postictalpsychosispresymptomaticriskfactorsandtheneedforfurtherinvestigationofgeneticsandpharmacotherapy
AT bromfieldedwardb postictalpsychosispresymptomaticriskfactorsandtheneedforfurtherinvestigationofgeneticsandpharmacotherapy
AT fricchionegregory postictalpsychosispresymptomaticriskfactorsandtheneedforfurtherinvestigationofgeneticsandpharmacotherapy